Literature DB >> 16134776

A case of erythema nodosum and serositis associated with myelodysplastic syndrome.

Jung-Hye Choi1, Myung-Ju Ahn, Yong-Wook Park, Ho-Suk Oh, Young-Yeul Lee, In-Soon Kim.   

Abstract

Myelodysplastic syndrome (MDS) is a heterogenous group of stem cell disorders usually characterized by progressive refractory cytopenias, which could progress to acute myeloid leukemia. MDS may be associated with a wide spectrum of skin lesions, including neoplastic cell infiltration, Sweet's syndrome, pyoderma gangrenosum, erythema elevatum diutinum, vasculitis, and panniculitis. However, erythema nodosum is rarely associated with MDS. Unusual rheumatologic manifestations in patients with MDS also have been reported, which range from asymptomatic serological abnormalities to classic connective tissue disorders such as Sjögren's syndrome, relapsing polychondritis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. However, concurrent erythema nodosum and serositis has rarely been reported. We describe a case of MDS with erythema nodosum and immune-mediated pericardial effusion in a 34-year-old woman.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134776      PMCID: PMC3891390          DOI: 10.3904/kjim.2005.20.2.177

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  12 in total

Review 1.  Myelodysplastic syndrome and associated skin lesions: a review of the literature.

Authors:  I Avivi; H Rosenbaum; Y Levy; J Rowe
Journal:  Leuk Res       Date:  1999-04       Impact factor: 3.156

2.  [Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology].

Authors:  S Bohn; S Büchner; P Itin
Journal:  Schweiz Med Wochenschr       Date:  1997-07-08

Review 3.  Rheumatic manifestations in myelodysplastic syndromes.

Authors:  M Castro; D L Conn; W P Su; J P Garton
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

Review 4.  Erythema nodosum and Hodgkin's disease.

Authors:  A Bonci; V Di Lernia; F Merli; G Lo Scocco
Journal:  Clin Exp Dermatol       Date:  2001-07       Impact factor: 3.470

5.  Sweet's syndrome evolved from recurrent erythema nodosum in a patient with myelodysplastic syndrome.

Authors:  Wataru Nishie; Tetsunori Kimura; Michiyo Kanagawa
Journal:  J Dermatol       Date:  2002-02       Impact factor: 4.005

Review 6.  Biology of myelodysplastic syndromes.

Authors:  Y Yoshida
Journal:  Int J Cell Cloning       Date:  1987-09

7.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Authors:  H Enright; H S Jacob; G Vercellotti; R Howe; M Belzer; W Miller
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

8.  Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies.

Authors:  G J Mufti; A Figes; T J Hamblin; D G Oscier; J A Copplestone
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

9.  Immunologic indices in myelodysplastic syndromes.

Authors:  P H Colombat; M Renoux; J P Lamagnere; G Renoux
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

10.  Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.

Authors:  P V Kuzmich; G A Ecker; J Karsh
Journal:  J Rheumatol       Date:  1994-09       Impact factor: 4.666

View more
  1 in total

1.  Clinical Characteristics of Patients with Erythema Nodosum and Risk of Relapse - a 17-Year Study.

Authors:  Petros Ioannou; Angeliki M Andrianaki; Dimitra Dimopoulou; Sabine Kruger-Krasagakis; Dimitra Koumaki; Diamantis P Kofteridis; George Samonis; Konstantinos Krasagakis
Journal:  Maedica (Bucur)       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.